W. Mutombo

Nifurtimox-efl ornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis : a multicentre , randomised , phase III , non-inferiority trial

V. Kande, E. Torreele, M. Ilunga, 2009 .

In-Hospital Safety in Field Conditions of Nifurtimox Eflornithine Combination Therapy (NECT) for T. b. gambiense Sleeping Sickness

Salah Ghabri, Johannes Blum, S. Blesson, 2012, PLoS neglected tropical diseases.

Effectiveness of Nifurtimox Eflornithine Combination Therapy (NECT) in T. b. gambiense second stage sleeping sickness patients in the Democratic Republic of Congo: Report from a field study

C. Burri, S. Blesson, V. Kande, 2021, PLoS neglected tropical diseases.

Prescription of concomitant medications in patients treated with Nifurtimox Eflornithine Combination Therapy (NECT) for T.b. gambiense second stage sleeping sickness in the Democratic Republic of the Congo

V. Kande, M. Ilunga, W. Mutombo, 2020, PLoS neglected tropical diseases.

Trypanosome SL-RNA detection in blood and cerebrospinal fluid to demonstrate active gambiense human African trypanosomiasis infection

A. Tarral, P. Büscher, V. Lejon, 2021, PLoS neglected tropical diseases.

Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial

Salah Ghabri, Els Torreele, Sara Ghorashian, 2009, The Lancet.

Trypanosome spliced leader RNA for diagnosis of acoziborole treatment outcome in gambiense human African trypanosomiasis: A longitudinal follow-up study

A. Tarral, P. Büscher, V. Lejon, 2022, EBioMedicine.